Weave Communications Inc(WEAV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.26 | Insider Own | 13.2% | Shs Outstand | 79.9M | Perf Week | 0.14% |
| Market Cap | 0.60B | Forward P/E | 30.83 | EPS next Y | 26.32% | Insider Trans | - | Shs Float | 69.8M | Perf Month | 0.27% |
| Enterprise Value | 0.57B | PEG | 0.5 | EPS next Q | 0.05 | Inst Own | 93.38% | Short Float | 5.33% | Perf Quarter | 13.15% |
| Income | -0.02B | P/S | 2.31 | EPS this Y | 137.5% | Inst Trans | 7.64% | Short Ratio | 1.28 | Perf Half Y | 50.71% |
| Sales | 0.26B | P/B | 6.96 | EPS next 5Y | 61.98% | ROA | -9.95% | Short Interest | 3.73M | Perf YTD | -2.5% |
| Book/sh | 1.06 | P/C | 7.59 | EPS past 3/5Y | 21.39% 11.11% | ROE | -25.08% | 52W High | -3.9% ($7.70) | Perf Year | 8.03% |
| Cash/sh | 0.98 | P/FCF | 54.02 | Sales past 3/5Y | 18.92% 24.5% | ROIC | -16.51% | 52W Low | 74.53% ($4.24) | Perf 3Y | 7.71% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 35.67% | Gross Margin | 72.18% | Volatility(W/M) | 0.19% 0.3% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.2 | Sales Y/Y TTM | 16.73% | Oper. Margin | -7.99% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.07 | EPS Q/Q | 53.44% | Profit Margin | -7.97% | RSI (14) | 62.73 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.07 | Sales Q/Q | 15.52% | SMA20 | 0.24% ($7.38) | Beta | 1.68 | Target Price | $7.4 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 2026/8/6 | SMA50 | 1.82% ($7.27) | Rel Volume | 0 | Prev Close | $7.4 |
| Employees | 904 | LT Debt/Eq | 0.46 | EPS/Sales Surpr. | 14.29% -0.49% | SMA200 | 20.39% ($6.15) | Avg Volume(3M) | 2.92M | Price | $7.4 |
| IPO | 2021/11/11 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
📞 A U.S. healthcare IT company that provides an AI-powered, all-in-one communication, patient engagement, and payment SaaS platform designed for small medical practices such as dental offices, optometry clinics, and veterinary hospitals. It unifies phone, texting, scheduling, payment, and reviews into a single workflow, digitizing the day-to-day operations of medical practices.
Over the past 1 year, on the higher side
4% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
WEAV has weak earning power
Of every $100 in sales, $7.99 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +137.5% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $231. Peers typically go for $181.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Long-term returns are roughly flat
Bought 3 years ago, your return today would be +7.7%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 93.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #19 of 41 in the industry
Based on market cap of $595M.
PHR#17 Phreesia Inc $778M PER 74.2 
SOPH#18 SOPHiA Genetics SA $678M PER - WEAV#19 Weave Communications Inc $595M PER - 
NRC#20 NRC Health $520M PER 84.5 
EVH#21 Evolent Health Inc $481M PER - 
FAQ
What kind of company is WEAV?
WEAV belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of WEAV?
The market cap of WEAV is approximately $595M, ranking 3,019 within its sector.
What is the 52-week high and low for WEAV?
WEAV has recorded a 52-week high of $7.70 and a low of $4.24.
